← back to search

Long Pei

Hebei Medical University · CN
Area of research
Molecular Biology · Cancer Research
Research interest
Research interests include Circular RNAs in diseases, MicroRNA in disease regulation, Cancer-related molecular mechanisms research, and RNA Research and Splicing.
h-index
8
citations
279
works
21
NIH funding
primary concept
email

Recent publications

circDHX33 suppresses glycolysis, malignant proliferation, and metastasis in prostate cancer by interacting with RNA-binding protein IGF2BP2 to destabilize its protein
Cytotechnology 2025cited by 2position: middledoi
Circular RNA Dipeptidyl Peptidase 4 (circDPP4) Stimulates the Expression of Glutamate Dehydrogenase 1 to Contribute to the Malignant Phenotypes of Prostate Cancer by Sponging miR-497-5p
Molecular Biotechnology 2023cited by 1position: firstdoi
Exosomal circRNA Scm-like with four malignant brain tumor domains 2 (circ-SFMBT2) enhances the docetaxel resistance of prostate cancer via the microRNA-136-5p/tribbles homolog 1 pathway
Anti-Cancer Drugs 2022cited by 23position: lastdoi
Higher TYROBP and lower SOX6 as predictive biomarkers for poor prognosis of clear cell renal cell carcinoma: A pilot study
Medicine 2022cited by 8position: middledoi
Identification of Prostate Cancer Risk Genetics Biomarkers Based on Intergraded Bioinformatics Analysis
Frontiers in Surgery 2022cited by 8position: middledoi
CircSCNN1A is a tumor suppressor in renal cell carcinoma via inducing the upregulation of MPP7 by the sponge effect on miR-421
Transplant Immunology 2022cited by 4position: firstdoi
Circular RNA circSDHC (hsa_circ_0015004) regulates tumor growth and angiogenesis via regulating centrosomal protein 55 expression in renal cell carcinoma.
PubMed 2022cited by 3position: firstdoi
The FAP -activated prodrug Z-GP-DAVLBH inhibits the growth and pulmonary metastasis of osteosarcoma cells by suppressing the AXL pathway
Acta Pharmaceutica Sinica B 2021cited by 37position: middledoi
Silencing circular RNA circ_0054537 and upregulating microRNA-640 suppress malignant progression of renal cell carcinoma via regulating neuronal pentraxin-2 (NPTX2)
Bioengineered 2021cited by 13position: firstdoi
lncRNA HCG11 regulates cell progression by targeting miR‐543 and regulating AKT/mTOR pathway in prostate cancer
Cell Biology International 2019cited by 57position: middledoi
Retroperitoneoscopic resection of retroperitoneal nonadrenal ganglioneuromas: our technique and clinical outcomes
International braz j urol 2018cited by 9position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Aili Zhang · Hebei Medical University5 papers (2021–2023)Xianqiang Lv · Hebei Medical University4 papers (2021–2022)Xiangdong Liang · Hebei Medical University4 papers (2022–2025)Xiaoliang Tan · Hebei Medical University3 papers (2021–2025)Xiaosen Song · Hebei Medical University3 papers (2022–2023)Gaopei Jia · Hebei Medical University3 papers (2021–2022)Chunhui Dong · Hebei Medical University2 papers (2022–2025)Xiaoliang Tan · Wuhan University2 papers (2022–2022)Wenyan He · China Pharmaceutical University1 papers (2019–2019)Xu Guo · Chinese PLA General Hospital1 papers (2022–2022)Zepei Fan · Guangzhou Regenerative Medicine and Health Guangdong Laboratory1 papers (2021–2021)Chang-jin Shi · Hebei Medical University1 papers (2018–2018)Yan‐Chao Wang · Hebei Medical University1 papers (2019–2019)Hu-Hu Zeng · Jinan University1 papers (2021–2021)Qing Wen · London School of Hygiene & Tropical Medicine1 papers (2021–2021)Maohua Huang · Jinan University1 papers (2021–2021)Jie Ouyang · Anhui University of Traditional Chinese Medicine1 papers (2021–2021)Kai-Bo Zhang · Central South University of Forestry and Technology1 papers (2022–2022)Wen‐Cai Ye · Shandong University1 papers (2021–2021)Junqiang Yin · Sun Yat-sen University1 papers (2021–2021)